This lecture covers the historical background of tumor antigens and the adaptive immune response, discussing the concept of anti-tumor immunity and the variability of the immune system. It delves into the mechanisms of anti-tumor immunity, focusing on dendritic cells, receptor activators, and danger signals. The lecture also explores strategies to enhance the immune response against tumors, such as cancer vaccines, monoclonal antibody therapies, and adoptive T cell transfer therapies.